홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 신약개발 > U.S. Drug Discovery Contract Research Organization Markets
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

U.S. Drug Discovery Contract Research Organization Markets

리서치사 Frost & Sullivan
발행일 2006년 09월 상품코드 45126
페이지 정보
가격
US $ 6,000 ￦ 7,149,000 Web Access (Regional License)
US $ 6,500 ￦ 7,744,700 Hard Copy & Web Access (Regional License)


영문목차

Abstract

Research Overview

This research service is available through our Pharmaceuticals & Clinical Diagnostics Growth Partnership Service program. With this program, you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils

Table of Contents

  • 1. Executive Summary
    • 1. Executive Summary
      • 1. Executive Summary
  • 2. Overview
    • 1. Overview
      • 1. Introduction
      • 2. Market Segmentation
      • 3. Research Methodology
      • 4. Market Engineering Measurements
  • 3. U.S. Drug Discovery Contract Research Organization Markets
    • 1. Market Drivers Restraints and Trends
      • 1. Market Drivers
      • a. Cost Pressures Encourage Research and Development (R&D) Outsourcing
      • b. Strong Growth of R&D Expenditure by Pharmaceutical and Biotechnology Companies Spurs Market Expansion
      • c. Aging Population and Shift from Acute to Chronic Products Drives Demand for Outsourcing
      • d. Limited Development Infrastructure with Biotechnology and Specialty Pharmaceutical Encourages Demand for Outsourcing
      • e. Robust Biotechnology Funding Drives Outsourcing Volumes
      • f. Toxicology Capacity Addition by Outsourcers Encourages Outsourcing Market Expansion
      • 2. Market Restraints
      • a. Increasing Competition and Commoditization of CRO Services Curtails Margins
      • b. Increasingly Stringent Regulatory Standards Pose an Ongoing Quality Challenge for CROs
      • c. Consolidation of the Pharmaceutical Industry Reduces Potential Revenues for Contract Research
      • d. Small CRO Size Limits Breadth of Offerings, While, Large Size Limits Flexibility
      • 3. Market Trends
    • 2. Revenue Forecasts Demand Analysis and Competitive Structure
      • 1. Revenue Forecasts
      • 2. Demand Analysis
      • 3. Competitive Structure
    • 3. Competitive Analysis
      • 1. Market Share Analysis
    • 4. Frost and Sullivan Awards
      • 1. Business Development Strategy Leadership Award
      • 2. Growth Strategy Leadership Award
      • 3. Market Leadership Award
  • 4. Challenges and Strategies
    • 1. Industry Challenges & Strategies
      • 1. Industry Challenges
      • 2. Strategies
  • 5. Decision Support Databases
    • 1. Pharmaceuticals and Biotechnology
      • 1. Pharmaceutical Research and Development Expenditure
      • 2. Biotechnology Companies
      • 3. Private Investment in Biotechnology Companies
      • 4. Biotechnology Government Research and Development Expenditure
    • 2. Macro Economic and Demographic Indicators
      • 1. Nominal GDP Growth
      • 2. Total Population
Back to Top